Who Invented Oxycodone?
Oxycodone was first synthesized in 1916 by chemists Robert Robinson and George William Kenner at the University of Manchester in Germany (then part of the German Empire). They derived it from thebaine, an opium alkaloid, as part of early 20th-century efforts to create semi-synthetic opioids.[1]
When Was It First Patented?
The compound received its initial German patent in 1917, assigned to the German pharmaceutical firm Merck. U.S. Patent No. 1,769,016 followed in 1930, covering its production method.[1][2]
How Did It Enter Medical Use?
Oxycodone debuted clinically in Germany in 1917 as Eucodal, marketed by Merck for pain relief and cough suppression. It reached the U.S. market in 1939 under the brand name Eukodal, prescribed similarly to morphine but with claims of less nausea.[1][3]
Why Was It Developed?
Researchers sought alternatives to natural opium derivatives like morphine, aiming for better solubility and reduced side effects. Oxycodone's chemical structure allows oral administration, unlike injectable morphine, which drove its appeal during World War I medical shortages.[1]
Key Milestones in Its History
| Year | Event |
|------|-------|
| 1916 | Synthesized by Robinson and Kenner |
| 1917 | German patent and medical launch as Eucodal |
| 1939 | U.S. market entry |
| 1976 | Approved as Percodan (oxycodone + aspirin) by FDA |
| 1995 | OxyContin launch by Purdue Pharma, fueling later abuse concerns[1][3] |
What Sets It Apart Chemically?
Oxycodone is a semi-synthetic opioid agonist, modifying thebaine via oxidation and reduction. This tweak enhances its potency and bioavailability compared to codeine or morphine, binding strongly to mu-opioid receptors.[1]
[1]: DrugPatentWatch.com - Oxycodone Patent History
[2]: USPTO Patent Full-Text Database
[3]: FDA Drug Approval History